RBC Capital Reiterates Outperform on Exelixis, Maintains $34 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Gregory Renza has reiterated an Outperform rating for Exelixis (NASDAQ:EXEL) and maintained a price target of $34.
October 30, 2024 | 3:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated its Outperform rating for Exelixis, maintaining a price target of $34, indicating confidence in the company's performance.
The reiteration of an Outperform rating and a maintained price target of $34 by RBC Capital suggests a positive outlook for Exelixis. This can lead to increased investor confidence and potentially a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100